HomeAbout UsServices
Industries Served
Industries Served
Technology: Biotechnology/Drugs

Computer Services  |   Electronic Products  |   Software  |   Telecommunications  |   Instruments & Process Controls  |   Internet Services  |   Biotechnology/Drugs  |   Medical Products

Locating relevant advice and support, at the right time is critical for biotechnology and pharmaceutical firms.

From early stage product development, intellectual property protection, and financings options to the divestiture or acquisition of entire companies, it is imperative that you partner with a firm that possess the credentials enabling you the greatest return for your efforts.

Capital Alliance has expertise in the industry for a wide range of biotechnology segments, including:

  • Research and development companies
  • Pharmaceutical manufacturing companies
  • Engineering and service providers
  • Life science firms
  • Equipment and product providers
  • Other biotechnology and pharmaceutical products and services

Some of the companies Capital Alliance has interacted with in the biotechnology/
drugs industry:
Smithkline Beecham Johnson & Johnson Bayer
     
Abbott Laboratories
     
     
     
     
   

 

We Have Buyers

  • Professionals in our firm have personal working relationships with thousands of buyers.
    • Over 8,000 buyers have interacted with our firm on programs we have conducted for sellers.
    • We interact with over 400 Private Equity Groups with very broad acquisition interests that each have over $100 million under management.
    • We are skilled at uncovering the best buyer prospects
      • from thousands of buyers we know
      • reviewing recent M&A transactions
      • using purchased databases consisting of over 400,000 buyers throughout the world
      • using the extensive worldwide network of M&A International
      • through our Biotechnology/Drugs industry awareness
        • personal industry contacts
        • monitoring major competitive actions
        • knowing major industry trends
  • In the Biotechnology/Drugs industry, we know who
    • has bought recently
    • is currently buying and why
The Way We Work
  • As your trusted advisor
    • with unique industry experience
    • extensive transaction experience
  • We have the same basic interests as minority shareholders
  • We will guide you from start to finish
    • Establish transaction goals
    • Prepare a superior marketing-oriented description of your firm
    • Select the best acquirer prospects
    • Establish introductory acquirer meetings
    • Negotiate aggressively
    • Establish Letters of Intent
    • Assist in investigative efforts
    • Interface with accountants and lawyers from both sides
    • Close the transaction
Finding The Best Fit
  • A well-matched acquirer can offer synergies in
    • Operations
    • Distribution
    • Technology
    • Management style
  • Besides money, a well-matched acquirer brings
    • Management oversight
    • Industry contacts
    • Better access to capital markets
  • Getting a well-matched acquirer requires
    • An extensive contact base
    • Proven methods to properly process prospects
Why You Should Engage Capital Alliance
  • Proven track record
  • Can deliver premium cash prices
  • Extensive negotiating expertise
  • Biotechnology/Drugs industry knowledge and experience
  • Corporate operating expertise
  • A systematic approach that works
  • Proven methods to achieve our client's goals

Top of page